Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies ; volume:24 ; number:1 ; day:19 ; month:2 ; year:2024 ; pages:1-16 ; date:12.2024
BMC cancer ; 24, Heft 1 (19.2.2024), 1-16, 12.2024
- Creator
-
Yu, Xiao-wan
She, Pei-wei
Chen, Fang-chuan
Chen, Ya-yu
Zhou, Shuang
Wang, Xi-min
Lin, Xiao-rong
Liu, Qiao-ling
Huang, Zhi-jun
Qiu, Yu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-11890-x
- URN
-
urn:nbn:de:101:1-2404260726433.340712953573
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yu, Xiao-wan
- She, Pei-wei
- Chen, Fang-chuan
- Chen, Ya-yu
- Zhou, Shuang
- Wang, Xi-min
- Lin, Xiao-rong
- Liu, Qiao-ling
- Huang, Zhi-jun
- Qiu, Yu
- SpringerLink (Online service)
Other Objects (12)
Optimization of personalized therapies for anticancer treatment
Immune landscapes associated with different glioblastoma molecular subtypes
Determinants in Tailoring Antidiabetic Therapies: A Personalized Approach
Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer
Genetic and Epigenetic Landscapes of Pediatric Acute Lymphoblastic Leukemia Subtypes
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
Personalized medicine: risk prediction, targeted therapies and mobile health technology
Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies
Molecular breast cancer subtypes and therapies in a public hospital of Northeastern Brazil
Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer
Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies
The integrated molecular and histological analysis defines subtypes of esophageal squamous cell carcinoma
Optimization of personalized therapies for anticancer treatment
Immune landscapes associated with different glioblastoma molecular subtypes
Determinants in Tailoring Antidiabetic Therapies: A Personalized Approach
Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer
Genetic and Epigenetic Landscapes of Pediatric Acute Lymphoblastic Leukemia Subtypes
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
Personalized medicine: risk prediction, targeted therapies and mobile health technology
Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies
Molecular breast cancer subtypes and therapies in a public hospital of Northeastern Brazil
Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer
Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies
The integrated molecular and histological analysis defines subtypes of esophageal squamous cell carcinoma
Optimization of personalized therapies for anticancer treatment
Immune landscapes associated with different glioblastoma molecular subtypes
Determinants in Tailoring Antidiabetic Therapies: A Personalized Approach
Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer
Genetic and Epigenetic Landscapes of Pediatric Acute Lymphoblastic Leukemia Subtypes
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
Personalized medicine: risk prediction, targeted therapies and mobile health technology
Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies
Molecular breast cancer subtypes and therapies in a public hospital of Northeastern Brazil
Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer
Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies